| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 82621 |
cas:2055024-54-7 Boc-PEG4-Val-Cit-PAB-OH |
161 |
zyl |
2024-12-19 |
| 82622 |
Fmoc-PEG3-Ala-Ala-Asn(Trt)-PAB-PNP（CAS: 2055042-82-3） |
145 |
WYQ |
2024-12-19 |
| 82623 |
Mal-amido-PEG8-val-gly-PAB-OH（CAS: 2353409-52-4） |
149 |
WYQ |
2024-12-19 |
| 82624 |
cas:160854-54-6，4-succinimidyl-oxycarbonyl-α-(2-pyridyldithio)toluene，ADC定制 |
139 |
wyh |
2024-12-19 |
| 82625 |
cas:2504147-59-3 MC (C5)-Val-Cit |
170 |
zyl |
2024-12-19 |
| 82626 |
Boc-PEG4-Val-Ala-PAB，可降解的ADC连接体 |
174 |
WYQ |
2024-12-19 |
| 82627 |
cas:2058075-34-4，DGN549-C ， ADC试剂 |
235 |
kx |
2024-12-19 |
| 82628 |
CAS: 1639939-40-4，Mal-Val-Ala-PAB-PNP，马来酰亚胺-VAL-ALA-PAB-PNP |
170 |
WYQ |
2024-12-19 |
| 82629 |
Fmoc-VC-PAB-Duocarmycin SA， ADC试剂 |
131 |
kx |
2024-12-19 |
| 82630 |
Mal-PEG4-Val-Ala-PAB，可降解的ADC（抗体偶联药物）连接子 |
225 |
WYQ |
2024-12-19 |
| 82631 |
Mal-PEG1-Val-Cit-OH的介绍 |
176 |
zyl |
2024-12-19 |
| 82632 |
MC-vc-PAB-Monomethyl dolastatin10， ADC试剂 |
121 |
kx |
2024-12-19 |
| 82633 |
CAS: 1870916-87-2，Mal-Val-Ala-PAB，马来酰亚胺-缬氨酸-丙氨酸-对氨基苯甲酸 |
152 |
WYQ |
2024-12-19 |
| 82634 |
cas:2395887-69-9 Mal-PEG2-Val-Cit-PAB-PNP |
130 |
zyl |
2024-12-19 |
| 82635 |
SuO-Val-Cit-PAB-MMAE， ADC试剂 |
125 |
kx |
2024-12-19 |
| 82636 |
Mal-PEG4-Val-Ala-PAB-PNP的介绍 |
128 |
zyl |
2024-12-19 |
| 82637 |
CAS: 2348405-93-4，DBCO-PEG4-Val-Ala-PAB-PNP |
117 |
WYQ |
2024-12-19 |
| 82638 |
CAS: 2348405-92-3，DBCO-PEG4-Val-Ala-PAB |
135 |
WYQ |
2024-12-19 |
| 82639 |
cas:2112738-13-1 Mal-amido-PEG2-Val-Cit-PAB-PNP |
137 |
zyl |
2024-12-19 |
| 82640 |
Azido-PEG4-Val-Ala-PAB，分子式：C29H48N8O9 |
126 |
WYQ |
2024-12-19 |
| 82641 |
cas:2055896-86-9，MC-Val-Cit-PAB-tubulysin5a ， ADC试剂 |
132 |
kx |
2024-12-19 |
| 82642 |
Azido-PEG8-Val-Cit-PAB-PNP |
121 |
zyl |
2024-12-19 |
| 82643 |
cas:2055896-83-6，MC-Val-Cit-PAB-carfilzomib ， ADC试剂 |
140 |
kx |
2024-12-19 |
| 82644 |
MAL-di-EG-Val-Cit-PAB-MMAF， ADC试剂 |
116 |
kx |
2024-12-19 |
| 82645 |
cas:2353409-45-5 endo BCN-PEG3-VC-PFP Ester |
147 |
zyl |
2024-12-19 |
| 82646 |
Hydrazone-doxorubicin， ADC试剂 |
243 |
kx |
2024-12-19 |
| 82647 |
DBCO-C4-Val-Cit-PABC-PNP |
135 |
zyl |
2024-12-19 |
| 82648 |
cas:644981-35-1 Val-Cit-PAB-MMAE |
134 |
zyl |
2024-12-19 |
| 82649 |
cas:170908-81-3，DOTA-NHS ester ，1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸 1-(2,5-二氧代-1-吡咯烷基)酯 |
113 |
kx |
2024-12-19 |
| 82650 |
endo-BCN-PEG4-Val-Cit-PAB-MMAE的介绍 |
127 |
zyl |
2024-12-19 |
| 82651 |
cas:2259318-50-6，MA-PEG4-VA-PBD ， ADC试剂 |
198 |
kx |
2024-12-19 |
| 82652 |
CAS: 2259318-55-1 - DBCO-(PEG2-VC-PAB-MMAE)2 |
95 |
WYQ |
2024-12-19 |
| 82653 |
CAS: 2768446-73-5，DBCO-Val-Cit-PAB-MMAE |
123 |
WYQ |
2024-12-19 |
| 82654 |
MC-vc-PAB-C6-a-amanitin， ADC试剂 |
119 |
kx |
2024-12-19 |
| 82655 |
cas:663598-98-9，2,5-dioxopyrrolidin-1-yl 4-methyl-4-((5-nitropyridin-2-yl)disulfanyl)pentanoate，ADC定制 |
127 |
wyh |
2024-12-19 |
| 82656 |
cas:2873452-49-2 MC-EVCit-PAB-MMAE |
124 |
zyl |
2024-12-19 |
| 82657 |
2,5-dioxopyrrolidin-1-yl 3-methyl-3-(pyridin-2-yldisulfanyl)butanoate，ADC定制 |
152 |
wyh |
2024-12-19 |
| 82658 |
cas:159857-70-2 MC-Val-Cit-Doxorubicin |
153 |
zyl |
2024-12-19 |
| 82659 |
Gly3-vc-PAB-MMAE， ADC试剂 |
156 |
kx |
2024-12-19 |
| 82660 |
CAS: 1869126-64-6， Azido-PEG4-Val-Cit-PAB-MMAE |
135 |
WYQ |
2024-12-19 |
| 82661 |
cas:2353409-54-6 ， Mal-amido-PEG8-Val-Gly，ADC定制 |
154 |
wyh |
2024-12-19 |
| 82662 |
Azido-PEG4-Val-Ala-PAB-PNP |
149 |
zyl |
2024-12-19 |
| 82663 |
NOTA-(NGR)2 NOTA偶联NGR二聚体 |
118 |
h |
2024-12-19 |
| 82664 |
1-(2,5-dioxopyrrolidin-1-yloxy)-4-((5-nitropyridin-2-yl)disulfanyl)-1-oxobutane-2-sulfonic acid，ADC定制 |
117 |
wyh |
2024-12-19 |
| 82665 |
CAS: 1343476-44-7，Val-Ala-PAB-OH |
114 |
WYQ |
2024-12-19 |
齐岳微信公众号
官方微信
库存查询